Loading clinical trials...
Loading clinical trials...
Randomized Controlled Trial Examining the Effect of Subcutaneous Xylocaine 2% on the Incidence of Vasovagal Reactions and Pain Intensity During Femoral Artery Sheath Removal.
This randomized controlled trial will examine the impact of local anesthetic on the frequency of vasovagal reactions and the patients perception of pain during femoral arterial sheath removal after percutaneous coronary intervention.
Patients undergoing percutaneous coronary intervention(PCI) will be randomized to receive subcutaneous local anesthetic (Lidocaine 2% without epinephrine)or no local prior to removal of femoral arterial sheath. They will be assessed for vasovagal reactions and pain intensity during the sheath removal.The incidence of vasovagal reactions and pain intensity scores will be compared between the groups. 200 patients will be enrolled over the course of 2 months.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
Yes
Hamilton Health Science-Heart Investigation Unit
Hamilton, Ontario, Canada
Start Date
May 1, 2007
Primary Completion Date
September 1, 2007
Completion Date
September 1, 2007
Last Updated
August 22, 2008
78
ACTUAL participants
Subcutaneous Lidocaine 2% (Xylocaine) without epinephrine
DRUG
Lead Sponsor
Hamilton Health Sciences Corporation
NCT06472102
NCT06440291
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06784986